166 related articles for article (PubMed ID: 23759086)
1. Uterine artery pulsatility index improves prediction of methotrexate resistance in women with gestational trophoblastic neoplasia with FIGO score 5-6.
Sita-Lumsden A; Medani H; Fisher R; Harvey R; Short D; Sebire N; Savage P; Lim A; Seckl MJ; Agarwal R
BJOG; 2013 Jul; 120(8):1012-5. PubMed ID: 23759086
[TBL] [Abstract][Full Text] [Related]
2. Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study.
Harvey RA; Elias KM; Lim A; Bercow A; Short D; Horowitz NS; Berkowitz RS; Agarwal R; Seckl MJ
Curr Probl Cancer; 2021 Feb; 45(1):100622. PubMed ID: 32800689
[TBL] [Abstract][Full Text] [Related]
3. Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia.
Agarwal R; Harding V; Short D; Fisher RA; Sebire NJ; Harvey R; Patel D; Savage PM; Lim AK; Seckl MJ
Br J Cancer; 2012 Mar; 106(6):1089-94. PubMed ID: 22374461
[TBL] [Abstract][Full Text] [Related]
4. Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors.
Agarwal R; Strickland S; McNeish IA; Patel DC; Foskett M; Boultbee JE; Newlands ES; Seckl MJ
Clin Cancer Res; 2002 May; 8(5):1142-7. PubMed ID: 12006530
[TBL] [Abstract][Full Text] [Related]
5. Sonographic characteristics of post-molar gestational trophoblastic neoplasia at diagnosis and during follow-up, and relationship with methotrexate resistance.
Epstein E; Joneborg U
Ultrasound Obstet Gynecol; 2020 Nov; 56(5):759-765. PubMed ID: 31909527
[TBL] [Abstract][Full Text] [Related]
6. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
7. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W
Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928
[TBL] [Abstract][Full Text] [Related]
8. Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study.
Frijstein MM; Lok C; van Trommel NE; Ten Kate-Booij MJ; Massuger L; van Werkhoven E; Short D; Aguiar X; Fisher RA; Kaur B; Sarwar N; Sebire NJ; Seckl MJ
BJOG; 2020 Feb; 127(3):389-395. PubMed ID: 31794098
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC).
Verhoef L; Baartz D; Morrison S; Sanday K; Garrett AJ
Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):458-463. PubMed ID: 28345753
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom.
Taylor F; Short D; Winter MC; Tidy J; Savage PM; Sarwar N; Hancock BW; Seckl MJ; Coleman RE
Gynecol Oncol; 2015 Feb; 136(2):258-63. PubMed ID: 25542400
[TBL] [Abstract][Full Text] [Related]
11. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
[TBL] [Abstract][Full Text] [Related]
13. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE
Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384
[TBL] [Abstract][Full Text] [Related]
14. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
15. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
Strohl AE; Lurain JR
Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
[TBL] [Abstract][Full Text] [Related]
16. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
[TBL] [Abstract][Full Text] [Related]
17. Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.
Agarwal R; Alifrangis C; Everard J; Savage PM; Short D; Tidy J; Fisher RA; Sebire NJ; Harvey R; Hancock BW; Coleman RE; Seckl MJ
J Reprod Med; 2014; 59(1-2):7-12. PubMed ID: 24597279
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
Kizaki S; Hashimoto K; Matsui H; Usui H; Shozu M
Gynecol Oncol; 2015 Dec; 139(3):429-32. PubMed ID: 26456138
[TBL] [Abstract][Full Text] [Related]
19. Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women.
Uberti EM; Fajardo Mdo C; da Cunha AG; Frota SS; Braga A; Ayub AC
Rev Bras Ginecol Obstet; 2015 Jun; 37(6):258-65. PubMed ID: 26200823
[TBL] [Abstract][Full Text] [Related]
20. [Curative effects and influenced factors of primary chemotherapy with single-agent methotrexate on low-risk gestational trophoblastic neoplasia].
Wu XD; Chen LL; Shen T; Chen SS; Chen QQ; Qin JL; Fu YF; Lü WG
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1769-1772. PubMed ID: 28647996
[No Abstract] [Full Text] [Related]
[Next] [New Search]
